Cite
HARVARD Citation
Alkharabsheh, O. et al. (n.d.). The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS. American journal of hematology. 93 (11), pp. E355-E357. [Online].